Sign in
MLPH Stock Price, Chart, Stats & News
Molecular Pharmacology (USA), Ltd.
Save
Molecular Pharmacology (USA), Ltd. (MLPH) does not currently pay a dividend.
643,711
Market cap
–
Current P/E
–
Forward P/E
MLPH chart
1M
3M
1Y
5Y
Loading chart...
About
Health care
Sector
Biotechnology
Industry
As a development-stage company, Molecular Pharmacology (USA) Limited (MLPH) is dedicated to the creation and market introduction of solutions for pain and inflammation, with a primary focus on the Australian and United States markets. Through its subsidiary, Molecular Pharmacology Pty. Ltd., it is advancing an analgesic and anti-inflammatory molecule called Tripeptofen, designed to alleviate common daily pain.
Similar securities
Based on sector and market capitalization
Report issue